The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals - time to reconsider strict pharmacopoeial limits?
Abstract HEPES (4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid) is a buffer that is used in the radiolabelling of gallium-68 compounds. The beneficial effects of HEPES on molar activity in bioconjugates have been well described. Current strict regulations on the HEPES content in radiopharmaceut...
Saved in:
Main Authors: | Jannie le Roux (Author), Janke Kleynhans (Author), Sietske Rubow (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals
by: I. F. Antunes, et al.
Published: (2020) -
Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the <sup>68</sup>Zn(p,n)<sup>68</sup>Ga Reaction and Their Regulatory Aspects
by: Zarif Ashhar, et al.
Published: (2022) -
The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
by: Janke Kleynhans, et al.
Published: (2022) -
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
by: Simon A. M. Kaeppeli, et al.
Published: (2019) -
Good practices for 68Ga radiopharmaceutical production
by: Bryce J. B. Nelson, et al.
Published: (2022)